The ANOS1 gene helps guide the early development of nerve cells involved in smell and the brain signals that trigger puberty. If it does not work properly, a person may have a reduced or absent sense of smell and delayed or absent puberty. This gene plays an important role in the X-linked form of Kallmann syndrome, which can also affect fertility.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
ANOS1Gene function
What if the gene works
The ANOS1 gene helps guide cell movement during early development, especially for nerve cells that control smell and puberty hormones. It also supports normal formation of parts of the brain and kidneys.
Risk
What if the gene does not work
Variants in the ANOS1 gene can disrupt smell nerve development and hormone signaling, often causing absent or delayed puberty with reduced or absent sense of smell. Milder to more severe variants may also influence kidney development or cause mirror movements.
Treatment
What does that mean for your treatment
No ANOS1-specific treatment or management approach is currently established. Drug choices are usually based on the person’s hormone and fertility needs, using standard therapies rather than an ANOS1-targeted medicine. ANOS1 is also being studied as a biomarker and possible drug target in some cancers, but this has not led to established clinical treatment based on ANOS1.
Conditions associated with ANOS1
Gene function
What if the gene works
Before birth, the ANOS1 gene helps guide how certain nerve cells and tissues take shape. Its protein works outside cells, where it helps cells attach, move, and follow the right paths. Understanding what the ANOS1 gene does in the body helps explain how smell pathways and some brain connections form in an orderly way.
The ANOS1 gene helps cells stick to their surroundings and move in a coordinated way during early development. This supports orderly tissue shaping as organs and nerve pathways begin to form.
Its protein helps growing nerve fibers follow helpful surface cues as they extend toward their targets. This is especially important for building the smell pathways that connect the nose and brain.
ANOS1 also supports the migration of nerve cells that later help control reproductive hormone signals. By helping these cells reach the right brain areas before birth, it supports normal body timing later on.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ANOS1 gene can make the anosmin-1 protein shorter, unstable, or unable to bind properly to nearby cells, which weakens important signals during early development. Some variants also interfere with how the protein folds or is released from the cell. Milder changes may leave some protein activity, while more disruptive variants can lead to little or no working protein. In ANOS1 gene variants linked to Kallmann syndrome, this often influences how early features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the ANOS1 gene are best known for causing X-linked Kallmann syndrome, a condition with delayed or absent puberty and a reduced or absent sense of smell. In some families, ANOS1-related hypogonadotropic hypogonadism, meaning puberty does not start normally because brain hormone signals are too low, can occur with a normal sense of smell. The link between the ANOS1 gene and Kallmann syndrome is well established in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, though, one well-characterized variant in a particular gene may be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For ANOS1, risk is mostly shaped by the genetic change itself, especially in families with X-linked Kallmann syndrome, and symptoms can vary between relatives. There is not yet broadly confirmed evidence that lifestyle or everyday exposures meaningfully increase or lower this gene-related risk.
Inheritance of ANOS1 variants
Variants in the ANOS1 gene are inherited in an X linked pattern, most often described as X linked recessive. Because ANOS1 is on the X chromosome, a mother who carries an ANOS1 variant can pass it to sons and daughters, while a father passes his X chromosome only to daughters. Males who inherit the altered copy are more likely to have ANOS1 related Kallmann syndrome, while females who carry the variant may have no symptoms or milder features. This ANOS1 inheritance pattern explains why the condition is usually seen more often in males than in females.
What does my ANOS1 result mean for my family?
Changes in the ANOS1 gene usually follow an X-linked pattern, so family members on the mother’s side may also carry the change or be affected. Male relatives can be more likely to have delayed or absent puberty and a reduced sense of smell, while female relatives may carry the change and sometimes have milder features. Close relatives may want to review the family history and consider whether genetic testing has been discussed in the family.
Genetic information
Genetic testing
How you find out about variants
ANOS1 genetic testing looks for variants in the ANOS1 gene using a blood sample or saliva sample. A lab reads the gene’s DNA code to check for changes that may help explain delayed or absent puberty, a reduced sense of smell, or confirm an ANOS1 related diagnosis.
When should I consider getting a genetic test?
Genetic testing for the ANOS1 gene may be worth considering when puberty is very delayed or does not start, especially along with a reduced or absent sense of smell, low hormone levels, or a family history of the same pattern. It can also help explain some cases of infertility linked to ANOS1-related conditions.
A genetic result is only one part of your health story
Genetic findings can be informative, although what they reveal varies with the condition and the specific variant. Over time, the body is also affected by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work well for one person but less well or with more side effects for another. Some gene differences change how quickly a drug is broken down or how strongly the body responds to it. This kind of variation is common and can influence both how effective a medicine is and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work the same way for everyone. For many drugs, genes influence both how the body handles a medicine and how powerful its effects are. This information can support treatment choices that are more informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the ANOS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how your body responds to them, so general health concerns, side effects, or questions about treatment are best discussed with your doctor.
History
The ANOS1 gene entered medical history through studies of families in which delayed or absent puberty appeared together with a reduced sense of smell, a pattern later linked to X linked Kallmann syndrome. Inheritance patterns were noticed long before the gene was identified. In the early 1990s, researchers mapped and cloned this gene on the X chromosome, first naming it KAL1. That discovery helped explain why some families showed a clear inherited pattern affecting boys more often than girls. Scientific classifications changed as researchers learned more about the gene, and KAL1 was later renamed ANOS1 to better reflect its link to loss of smell. These steps made ANOS1 an important part of the history of reproductive and developmental genetics.